TCMD (Tactile Systems Technology, Inc.) Stock Analysis - Financials

Tactile Systems Technology, Inc. (TCMD) is a publicly traded Healthcare sector company. As of May 20, 2026, TCMD trades at $24.75 with a market cap of $533.46M and a P/E ratio of 27.70. TCMD moved +2.64% today. Year to date, TCMD is -17.56%; over the trailing twelve months it is +138.85%. Its 52-week range spans $8.61 to $37.77. Analyst consensus is strong buy with an average price target of $39.50. Rallies surfaces TCMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are TCMD's key financials?

TCMD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TCMD recently traded at $24.75. Market cap is $533.46M. P/E ratio is 27.70. Revenue is $343.52M.

TCMD Key Metrics

Key financial metrics for TCMD
MetricValue
Price$24.75
Market Cap$533.46M
P/E Ratio27.70
EPS$0.89
Dividend Yield0.00%
52-Week High$37.77
52-Week Low$8.61
Volume150.42K
Avg Volume0
Revenue (TTM)$343.52M
Net Income$20.30M
Gross Margin76.39%

TCMD Annual Financials

YearRevenueNet IncomeEPS
2025$329.52M$19.09M$0.83
2024$292.98M$16.96M$0.71
2023$274.42M$28.52M$1.24
2022$246.78M$-17.87M$-0.89

Latest TCMD News

Recent TCMD Insider Trades

  • Birkemeyer Elaine M. sold 4.63K (~$113.40K) on May 11, 2026.
  • Dodd Sheri Louise sold 10.99K (~$318.14K) on Feb 24, 2026.
  • Birkemeyer Elaine M. sold 7.70K (~$222.88K) on Feb 24, 2026.

TCMD Analyst Consensus

5 analysts cover TCMD: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $39.50.

Common questions about TCMD

What are TCMD's key financials?
TCMD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TCMD recently traded at $24.75. Market cap is $533.46M. P/E ratio is 27.70. Revenue is $343.52M.
Is TCMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TCMD. It does not provide personalized investment advice.
TCMD

TCMD